
Top Investor Weighs in on UnitedHealth Stock's Future Risks
UnitedHealth's stock has fallen over 50% since April due to earnings misses and guidance cuts, but top investor James Foord believes the worst is priced in and sees a potential 30% upside, citing the company's strong market position and recent insider buying. Wall Street remains cautiously optimistic with a moderate buy consensus and a 20% upside target.
